DE69619540D1 - Arzneimittel enthaltend blutplättchenaggregationsinhibitoren - Google Patents

Arzneimittel enthaltend blutplättchenaggregationsinhibitoren

Info

Publication number
DE69619540D1
DE69619540D1 DE69619540T DE69619540T DE69619540D1 DE 69619540 D1 DE69619540 D1 DE 69619540D1 DE 69619540 T DE69619540 T DE 69619540T DE 69619540 T DE69619540 T DE 69619540T DE 69619540 D1 DE69619540 D1 DE 69619540D1
Authority
DE
Germany
Prior art keywords
products containing
medicinal products
containing blood
aggregation inhibitors
blood plate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69619540T
Other languages
English (en)
Other versions
DE69619540T2 (de
Inventor
Karl M Gelotte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Iroko Cardio LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE69619540D1 publication Critical patent/DE69619540D1/de
Publication of DE69619540T2 publication Critical patent/DE69619540T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69619540T 1995-10-27 1996-10-23 Arzneimittel enthaltend blutplättchenaggregationsinhibitoren Expired - Lifetime DE69619540T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (2)

Publication Number Publication Date
DE69619540D1 true DE69619540D1 (de) 2002-04-04
DE69619540T2 DE69619540T2 (de) 2002-08-22

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69619540T Expired - Lifetime DE69619540T2 (de) 1995-10-27 1996-10-23 Arzneimittel enthaltend blutplättchenaggregationsinhibitoren

Country Status (35)

Country Link
EP (1) EP0859634B1 (de)
JP (1) JP3452367B2 (de)
KR (1) KR100362799B1 (de)
CN (1) CN1158107C (de)
AT (1) ATE213648T1 (de)
AU (1) AU712755B2 (de)
BG (1) BG63623B1 (de)
BR (1) BR9610878A (de)
CA (1) CA2234364C (de)
CO (1) CO4770960A1 (de)
CY (1) CY2292B1 (de)
CZ (1) CZ290381B6 (de)
DE (1) DE69619540T2 (de)
DK (1) DK0859634T3 (de)
DZ (1) DZ2110A1 (de)
EA (1) EA000628B1 (de)
EE (1) EE03518B1 (de)
ES (1) ES2171749T3 (de)
HK (1) HK1017846A1 (de)
HU (1) HU228757B1 (de)
IL (1) IL123790A (de)
IS (1) IS1948B (de)
MX (1) MX9803275A (de)
MY (1) MY116837A (de)
NO (1) NO324415B1 (de)
NZ (1) NZ323134A (de)
PL (1) PL185744B1 (de)
PT (1) PT859634E (de)
SA (1) SA96170527B1 (de)
SI (1) SI0859634T1 (de)
SK (1) SK282353B6 (de)
TR (1) TR199800716T2 (de)
TW (1) TW385248B (de)
UA (1) UA45423C2 (de)
WO (1) WO1997015328A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
SI0859634T1 (en) 2002-04-30
DZ2110A1 (fr) 2002-07-22
BG102405A (en) 1999-08-31
JP3452367B2 (ja) 2003-09-29
TR199800716T2 (xx) 1998-07-21
CY2292B1 (en) 2003-07-04
EP0859634A1 (de) 1998-08-26
DE69619540T2 (de) 2002-08-22
PL185744B1 (pl) 2003-07-31
ATE213648T1 (de) 2002-03-15
PT859634E (pt) 2002-07-31
CN1200676A (zh) 1998-12-02
IS1948B (is) 2004-10-13
MX9803275A (es) 1998-09-30
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
CA2234364A1 (en) 1997-05-01
CZ290381B6 (cs) 2002-07-17
CO4770960A1 (es) 1999-04-30
KR100362799B1 (ko) 2003-07-16
CA2234364C (en) 2000-02-08
NO981869L (no) 1998-04-24
KR19990067020A (ko) 1999-08-16
BG63623B1 (bg) 2002-07-31
CN1158107C (zh) 2004-07-21
EA000628B1 (ru) 1999-12-29
HU228757B1 (en) 2013-05-28
NO324415B1 (no) 2007-10-08
HUP9902521A2 (hu) 1999-12-28
MY116837A (en) 2004-04-30
WO1997015328A1 (en) 1997-05-01
IS4699A (is) 1998-03-24
SK282353B6 (sk) 2002-01-07
AU712755B2 (en) 1999-11-18
UA45423C2 (uk) 2002-04-15
PL326419A1 (en) 1998-09-14
EP0859634B1 (de) 2002-02-27
TW385248B (en) 2000-03-21
EA199800336A1 (ru) 1998-10-29
IL123790A0 (en) 1998-10-30
NZ323134A (en) 1999-11-29
NO981869D0 (no) 1998-04-24
EE9800134A (et) 1998-10-15
IL123790A (en) 2001-11-25
HK1017846A1 (en) 1999-12-03
BR9610878A (pt) 1999-07-13
JPH10512296A (ja) 1998-11-24
AU7718996A (en) 1997-05-15
ES2171749T3 (es) 2002-09-16
CZ127898A3 (cs) 1998-10-14
SA96170527B1 (ar) 2005-12-21
SK51298A3 (en) 1998-12-02
EE03518B1 (et) 2001-10-15

Similar Documents

Publication Publication Date Title
MY100343A (en) Amide derivative and external medicament comprising same
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
GEP20032957B (en) Nonpeptidyl Compositions
AR007090A1 (es) Formula para administracion subcutanea que contiene fentanilo presentada en forma de cinta
DE68902301D1 (de) Diarylverbindungen als antiatherosklerotische mittel.
DE69619540D1 (de) Arzneimittel enthaltend blutplättchenaggregationsinhibitoren
KR900701262A (ko) 췌장염 등에 대한 치료제
KR880004810A (ko) 소화성 궤양 치료제
KR980002033A (ko) 트리아졸 유도체 또는 그 염
GB1312205A (en) Method and composition for lowering blood pressure
IE832939L (en) Pharmaceutical composition.
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
GB1530848A (en) 2-(phenylalkylhydrazono)-propionic acid derivatives
GB1468079A (en) Ethanolamine derivatives
KR900014360A (ko) 피리딘카복실산 아미드 유도체 및 이를 함유하는 약학 조성물
GB1267282A (en) Pharmaceutical compositions containing coumermycin derivatives
GB1268747A (en) Novel 2-naphthyl-2-hydroxy-acetamidine derivatives, their preparation and use
GB1384441A (en) Benzomorphan derivatives
GB1321541A (en) Sulphaguanidine derivatives
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
GB1463965A (en) Pharmaceutical compositions containing benzylamines

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: IROKO CARDIO, LLC, PHILADELPHIA, PA., US